The etiology of the tall stature almost invariably seen in homocystinuric patients is not known. The effect of metabolic control and the role of the GH-IGF system on growth were investigated in 10 patients with homocystinuria. There was a direct correlation between the plasma free homocyst(e)ine and growth velocity SD scores in 18 patient years (r, 0.46; p Ͻ 0.05). Plasma 2-y cumulative free homocyst(e)ine and height SD scores were directly correlated (r, 0.82; p Ͻ 0.01). Growth velocity SD scores were lower in patients with optimal metabolic control than in those with poorer control (Ϫ0.10 Ϯ 0.65 versus 0.95 Ϯ 0.68, p Ͻ 0.01). Height SD scores were also lower in the optimally controlled group (Ϫ0.01 Ϯ 0.81 versus 1.73 Ϯ 0.88, p Ͻ 0.05). GH and GH-related peptides did not deviate significantly from the reference ranges. These findings suggest that overgrowth is directly mediated by homocysteine, that the GH-IGF axis is not involved, and that it may be prevented by optimal metabolic control. Homocystinuria (McKusick 236200) due to cystathionine B-synthase (EC 4.2.1.22) deficiency is an inborn error of transsulfuration metabolism. The major biochemical abnormalities include elevation of HC and methionine and reduction of cystine in body fluids. Clinical manifestations include dislocation of the optic lens, mental retardation, psychiatric disturbances, thromboembolic phenomena, malar flush, livido reticularis, and skeletal abnormalities such as osteoporosis, scoliosis, arachnodactyly, and tall stature (1). It has been difficult to relate this wide variety of symptoms to a deficiency of a single enzyme. Thus, it has been classified as a connective tissue disorder, the result either of fibrillin damage or of impaired cross-linkage caused by complexing between aldehyde groups and HC. Although this may account for a number of the symptoms of the disease, it may not be responsible for the tall stature that has almost invariably been associated with the disease. Both HC and HCA, the sulfonic acid derivative of HC, have been suggested as the cause of the excessive growth. One study reported that HCA increased serum somatomedin activity in rats (2), whereas another study found that it accelerated the growth of guinea pigs (3). These findings have been challenged by other studies that have implicated HC as the agent responsible for growth (4,5). These studies have all been carried out either in animals or in cell lines derived from homocystinuric patients. However, the relationship of the growth pattern to the degree of metabolic control, as defined by the plasma HC, has not been evaluated in homocystinuric patients.Our interest in this excessive growth was stimulated by the observation that each of our patients diagnosed as the result of newborn screening and maintained in good metabolic control has grown at a rate similar to that of unaffected siblings, whereas patients diagnosed later in life have been excessively tall. In addition, the loss of metabolic control in several patients has precipitated a growth spurt. This l...